
Semen analysis as a routine health check for men sparks hype and skepticism
The piece explores the idea that routine semen analysis could serve as a broad biomarker for men’s health—potentially a “new Pap smear” that flags risks for metabolic, cardiovascular, and cancer conditions. Startups are offering mail-in and at-home testing to tap a growing market, while medical experts caution that there is insufficient evidence that broad semen screening improves health outcomes, and warn of logistical, ethical, and equity concerns and possible overdiagnosis.












